| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/06/2003 | WO2002085337B1 Micellar drug delivery systems for hydrophobic drugs |
| 02/06/2003 | WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/06/2003 | WO2002070516A3 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 02/06/2003 | WO2002070001A3 Use of lp82 to treat hematopoietic disorders |
| 02/06/2003 | WO2002067851A3 Method for treating fibrotic diseases or other indications iiic |
| 02/06/2003 | WO2002064586A3 Heterocyclic inhibitors of erk2 and uses thereof |
| 02/06/2003 | WO2002063005A3 Lipid-associated molecules |
| 02/06/2003 | WO2002061110A3 Nucleic acid derivatives |
| 02/06/2003 | WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors |
| 02/06/2003 | WO2002049666A3 Mycoplasma hyopneumoniae bacterin vaccine |
| 02/06/2003 | WO2002028904A3 Human anti-cd40 antibodies |
| 02/06/2003 | WO2002026240A9 Inhibition of antigen presentation with poorly catabolized polymers |
| 02/06/2003 | WO2002020722A3 Methods and compositions for in vitro targeting |
| 02/06/2003 | WO2002019963A3 Synthetic erythropoiesis stimulating proteins |
| 02/06/2003 | WO2002016413A8 Cripto tumour polypeptide |
| 02/06/2003 | WO2002010137A9 Indazole derivatives as jnk inhibitors |
| 02/06/2003 | WO2002002645A8 COLD WATER SOLUBLE β-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 02/06/2003 | WO2001088199A3 Identification and modulationof of a t helper-1 and t helper-2 cells |
| 02/06/2003 | US20030028029 Process for production of piperidine derivatives |
| 02/06/2003 | US20030028028 1-oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/06/2003 | US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders |
| 02/06/2003 | US20030028006 Cytokine receptor common gamma chain like |
| 02/06/2003 | US20030028000 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders |
| 02/06/2003 | US20030027999 143 human secreted proteins |
| 02/06/2003 | US20030027868 Aminoacetalization of camphor by reacting with NH4OH and suspending product in NaCl; preparation having a basic pH is then neutralised with nitric acid; product is an analogue of human cytokines |
| 02/06/2003 | US20030027867 Use of R-NSAID compounds for anti-HIV treatment |
| 02/06/2003 | US20030027852 Substituted pyrrolidine-2,3,4-trione 3-oxime deerivatives which are active as NMDA receptor antagonists |
| 02/06/2003 | US20030027851 Readily soluble crystal modification; specific X-ray diffraction pattern obtained with a focusing Debye-Scherrer beam and Cu-K alpha 1-radiation |
| 02/06/2003 | US20030027845 Ether derivatives useful as inhibitors of PDE4 isozymes |
| 02/06/2003 | US20030027814 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 02/06/2003 | US20030027806 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 02/06/2003 | US20030027794 N-heterocyclic derivatives as NOS inhibitors |
| 02/06/2003 | US20030027783 Introducing into the cell an RNA comprising a double stranded structure having nucleotide sequence which is substantially identical to part of target gene and which is derived from an endogenous template; verifying inhibition of expression |
| 02/06/2003 | US20030027782 Method for treating allergic lung disease |
| 02/06/2003 | US20030027774 For diagnosis and therapy of tuberculosis |
| 02/06/2003 | US20030027752 Leucine-based motif and clostridial neurotoxins |
| 02/06/2003 | US20030027358 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 02/06/2003 | US20030027337 Sequence-specific DNA recombination in eukaryotic cells |
| 02/06/2003 | US20030027283 Protein l and hybrid proteins thereof |
| 02/06/2003 | US20030027282 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 02/06/2003 | US20030027261 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 02/06/2003 | US20030027253 Nucleotides equences codin polypeptide for use in the treatment of cancer |
| 02/06/2003 | US20030027232 Novel compounds |
| 02/06/2003 | US20030027164 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 02/06/2003 | US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides |
| 02/06/2003 | US20030026805 Genetic engineering; monoclonal antibody grafted to tumor necrosis factor |
| 02/06/2003 | US20030026803 Compositions for inhibiting macrophage activity |
| 02/06/2003 | US20030026796 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
| 02/06/2003 | US20030026789 Anticancer agents |
| 02/06/2003 | CA2857312A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using deoxyhypusine synthase (dhs) |
| 02/06/2003 | CA2455602A1 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 02/06/2003 | CA2454822A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a |
| 02/06/2003 | CA2454805A1 Probiotic lactobacillus casei strains |
| 02/06/2003 | CA2454803A1 Probiotic bifidobacterium strains |
| 02/06/2003 | CA2454802A1 Novel class ii cytokine receptors and uses thereof |
| 02/06/2003 | CA2454564A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 02/06/2003 | CA2454469A1 Blood group antigen fusion polypeptides and methods of use thereof |
| 02/06/2003 | CA2454342A1 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 02/06/2003 | CA2453919A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands |
| 02/06/2003 | CA2453880A1 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 02/06/2003 | CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2452259A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/06/2003 | CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/05/2003 | WO2002014280A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 02/05/2003 | EP1281756A1 Regulator of calcineurin |
| 02/05/2003 | EP1281401A2 The medical effect of Jojoba oil |
| 02/05/2003 | EP1281400A2 Pharmaceutical compositions containing ascomycin derivatives |
| 02/05/2003 | EP1281398A1 Dermal compositions containing coenzyme q as the active ingredient |
| 02/05/2003 | EP1281397A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 02/05/2003 | EP1280924A2 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses |
| 02/05/2003 | EP1280908A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2 |
| 02/05/2003 | EP1280907A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 02/05/2003 | EP1280906A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 02/05/2003 | EP1280900A2 Dendritic cell co-stimulatory molecules |
| 02/05/2003 | EP1280897A2 Regulation of nf-at interacting protein nip 45 variant |
| 02/05/2003 | EP1280826A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 02/05/2003 | EP1280820A2 Anti-inflammatory compounds and uses thereof |
| 02/05/2003 | EP1280815A1 29 human secreted proteins |
| 02/05/2003 | EP1280806A1 THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS |
| 02/05/2003 | EP1280800A1 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd 23 |
| 02/05/2003 | EP1280799A1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 02/05/2003 | EP1280798A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 02/05/2003 | EP1280797A1 Inhibitors of dipeptidyl peptidase iv |
| 02/05/2003 | EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/05/2003 | EP1280776A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 02/05/2003 | EP1280774A1 Substituted indoles as parp inhibitors |
| 02/05/2003 | EP1280550A2 Electroporation for introduction of molecules into cells |
| 02/05/2003 | EP1280547A2 Mast cell regulation |
| 02/05/2003 | EP1280546A1 Method and composition for the treatment of angiogenesis |
| 02/05/2003 | EP1280544A1 Hyaluronidase activity and allergenic cell activity inhibitor |
| 02/05/2003 | EP1280543A2 Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom |
| 02/05/2003 | EP1280537A2 Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof |
| 02/05/2003 | EP1280524A2 Methods and compositions for modulating alpha adrenergic receptor activity |
| 02/05/2003 | EP1280416A1 Pet food composition for reducing inflammatory response in cats |
| 02/05/2003 | EP1200101A4 Methods for transdifferentiation of body tissues |
| 02/05/2003 | EP1117653B1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 02/05/2003 | EP0980242B1 Use of fumaric acid derivatives for the treatment of autoimmune diseases |
| 02/05/2003 | EP0909178B1 Interleukin-8 as an antiviral and antitumor agent |
| 02/05/2003 | EP0574512B1 Redirection of cellular immunity by receptor chimeras |